Reuters logo
BRIEF-Vectura confident on outlook for Novartis inhaler products
October 24, 2017 / 6:22 AM / 2 months ago

BRIEF-Vectura confident on outlook for Novartis inhaler products

Oct 24 (Reuters) - Vectura Group Plc

* Q3 2017 net sales of $101 million for ultibro ® breezhaler ® and $37 million for seebri ® breezhaler​

* ‍confirms its continued growth expectations for ultibro’s long term sales potential and outlook for recurring revenue generation for group​ Source text for Eikon: Further company coverage: (Reporting By London Bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below